A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer

  1. Tabernero, J.
  2. Climent, M.A.
  3. Lluch, A.
  4. Albanell, J.
  5. Vermorken, J.B.
  6. Barnadas, A.
  7. Antón, A.
  8. Laurent, C.
  9. Mayordomo, J.I.
  10. Estaun, N.
  11. Losa, I.
  12. Guillem, V.
  13. Garcia-Conde, J.
  14. Tisaire, J.L.
  15. Baselga, J.
Revue:
Annals of Oncology

ISSN: 0923-7534

Année de publication: 2004

Volumen: 15

Número: 9

Pages: 1358-1365

Type: Article

DOI: 10.1093/ANNONC/MDH349 GOOGLE SCHOLAR lock_openAccès ouvert editor